PREFINAL OSCE AND LEARNING POINTS
OSCE :
Tenegliptin :
It is a third generation DPP-4 inhibitor used for treatment of type 2 diabetes.
MECHANISM OF ACTION of Teneligliptin is to increase incretin levels (GLP-1 and GIP), which inhibit glucagon release, which in turn increases insulin secretion, decreases gastric emptying, and decreases blood glucose levels.
In general incretins (glucagon like peptides) are the substances which increase insulin and decrease appetite by decreasing the gastric emptying. DPP4 dipeptidyl peptide-4 is a enzyme which converts this incretins into its metabolites Which is inhibited by teneligliptin and maintain the levels of incretins which cause insulin release and decreasing the blood glucose levels
LEARNING POINTS:
My learning points about this patient are
- The importance taking detailed history from the patient before and after the onset of I'll health and how it affected his daily life routine
-Importance of Mechanism of action of every drug that is prescribed to the patient.
-Telling the importance of continuous usage of anti diabetic medications and problems he faces if he discontinues the medications as he done earlier.
-His long term fever and burning micturition might be because of urinary tract infection
Comments
Post a Comment